SE0001075D0 - Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases - Google Patents
Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseasesInfo
- Publication number
- SE0001075D0 SE0001075D0 SE0001075A SE0001075A SE0001075D0 SE 0001075 D0 SE0001075 D0 SE 0001075D0 SE 0001075 A SE0001075 A SE 0001075A SE 0001075 A SE0001075 A SE 0001075A SE 0001075 D0 SE0001075 D0 SE 0001075D0
- Authority
- SE
- Sweden
- Prior art keywords
- substance
- nicotine
- medicament
- manufacture
- treatment
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to a use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament to be supplied to an individual of a human being or an animal for the purpose of counteracting, in a prophylactic or therapeutic manner, obstructive lung diseases, in particular pulmonary emphysema. The medicament is intended to be supplied via the blood path and to be administered via the gastrointestinal tract, transdermally, intravascularly, intranasally or intravaginally. The invention also refers to a method for prophylactic or therapeutic treatment of obstructive lung diseases of an individual of a human being or an animal, wherein said individual is supplied with a nicotine-based substance.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0001075A SE0001075D0 (en) | 1999-09-01 | 2000-03-27 | Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases |
CA002382567A CA2382567A1 (en) | 1999-09-01 | 2000-09-01 | Use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament, and a method for treatment of obstructive lung disease |
AU70477/00A AU7047700A (en) | 1999-09-01 | 2000-09-01 | Use of at least one substance based on nicotine and/or a substance produced fromsaid one substance for the manufacture of a medicament, and a method for treatm ent of obstructive lung diseases |
EP00959096A EP1207883A1 (en) | 1999-09-01 | 2000-09-01 | Use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament, and a method for treatment of obstructive lung diseases |
PCT/SE2000/001683 WO2001015697A1 (en) | 1999-09-01 | 2000-09-01 | Use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament, and a method for treatment of obstructive lung diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903085A SE516807C2 (en) | 1999-09-01 | 1999-09-01 | Use of nicotine based substances to treat obstructive lung diseases |
SE0001075A SE0001075D0 (en) | 1999-09-01 | 2000-03-27 | Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0001075D0 true SE0001075D0 (en) | 2000-03-27 |
Family
ID=26655041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0001075A SE0001075D0 (en) | 1999-09-01 | 2000-03-27 | Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1207883A1 (en) |
AU (1) | AU7047700A (en) |
CA (1) | CA2382567A1 (en) |
SE (1) | SE0001075D0 (en) |
WO (1) | WO2001015697A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2341952A1 (en) * | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
US8557804B2 (en) | 2002-03-25 | 2013-10-15 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US8039459B2 (en) | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
WO2006005195A1 (en) * | 2004-07-15 | 2006-01-19 | UNIVERSITé LAVAL | Nicotinic receptor agonists for the treatment of inflammatory diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998034615A1 (en) * | 1997-02-07 | 1998-08-13 | Synapse Pharmaceuticals International, Inc. | Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
-
2000
- 2000-03-27 SE SE0001075A patent/SE0001075D0/en unknown
- 2000-09-01 AU AU70477/00A patent/AU7047700A/en not_active Abandoned
- 2000-09-01 CA CA002382567A patent/CA2382567A1/en not_active Abandoned
- 2000-09-01 WO PCT/SE2000/001683 patent/WO2001015697A1/en not_active Application Discontinuation
- 2000-09-01 EP EP00959096A patent/EP1207883A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2382567A1 (en) | 2001-03-08 |
WO2001015697A1 (en) | 2001-03-08 |
AU7047700A (en) | 2001-03-26 |
WO2001015697A8 (en) | 2002-01-03 |
EP1207883A1 (en) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118517T1 (en) | Pulmonary administration for levodopa | |
DE69526425D1 (en) | USE OF MOMETASONE-FUROAT TO TREAT AIR AND LUNG DISEASES | |
BR0311451A (en) | Liquid nicotine buffered composition for pulmonary administration | |
DK1406688T3 (en) | Respiratory device for keeping a human body's natural airways free, as well as application methods for preventing snoring sounds | |
CY1107981T1 (en) | PROVISION FOR CONTROLLED INSPECTION OF THERAPEUTIC | |
DE60002885D1 (en) | AQUEOUS FORMULATION FOR NASAL ADMINISTRATION | |
ATE144142T1 (en) | USE OF THIAZOLIDINE-4-CARBOXYLATE DERIVATIVES FOR THE TREATMENT OF LUNG DISEASES | |
SE0000601D0 (en) | Methods to treat and diagnose respiratory disorders in sleep and agents to perform the procedure | |
WO2003079993A3 (en) | hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION | |
EA200701077A1 (en) | APPLICATION OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES | |
SE0001075D0 (en) | Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases | |
EE04330B1 (en) | Transmucosal formulations of levosimendan and their use in the manufacture of a medicament | |
ATE271852T1 (en) | IMPROVED INHALATION PREPARATIONS | |
BR9914945A (en) | Process for providing medical / medicinal therapy | |
CN202844292U (en) | Trachea incision atomization cover | |
MXPA04002401A (en) | Novel medicaments for inhalation. | |
PL335758A1 (en) | Application bird's antibodies | |
CN210933232U (en) | Nasal plug fixing device for oxygen inhalation in cardiovascular department | |
SE9903085L (en) | Use of at least one nicotine-based substance and / or a substance prepared from this substance for the manufacture of a medicament | |
EA199900568A1 (en) | METHOD OF IMPROVING RESPIRATION IN DREAM | |
SU971336A1 (en) | Antiinflammatory agent for treating tuberculosis and non-specific chronic inflammatory diseases of lungs | |
JPH027570Y2 (en) | ||
Oswald | Expectoration of Shell Fragment after 29 years | |
Hargrove | Impaction of Gentian Pill in Larynx of Child aged 2 | |
Hicks et al. | " How I do it"--head and neck and plastic surgery. A targeted problem and its solution. A saliva shunting technique for low anterior neck pharyngeal fistulas after laryngectomy--an emergency procedure |